about
A Mutation in LTBP2 Causes Congenital Glaucoma in Domestic Cats (Felis catus)Replacing the enzyme alpha-L-iduronidase at birth ameliorates symptoms in the brain and periphery of dogs with mucopolysaccharidosis type I.Safe, efficient, and reproducible gene therapy of the brain in the dog models of Sanfilippo and Hurler syndromes.Early versus late treatment of spinal cord compression with long-term intrathecal enzyme replacement therapy in canine mucopolysaccharidosis type I.Active site mutant transgene confers tolerance to human beta-glucuronidase without affecting the phenotype of MPS VII mice.Production of MPS VII mouse (Gus(tm(hE540A x mE536A)Sly)) doubly tolerant to human and mouse beta-glucuronidaseRemoval of potentially confounding phenotypes from a Siamese-derived feline glaucoma breeding colony.Diffusion tensor imaging and myelin composition analysis reveal abnormal myelination in corpus callosum of canine mucopolysaccharidosis I.T Cell Lymphoma and Leukemia in Severe Combined Immunodeficiency Pigs following Bone Marrow Transplantation: A Case Report.Correction: A Mutation in LTBP2 Causes Congenital Glaucoma in Domestic Cats (Felis catus).Rescue of dystrophic skeletal muscle by PGC-1α involves restored expression of dystrophin-associated protein complex components and satellite cell signaling.Relationship of aging and cytokines to the immunomodulation by delta-9-tetrahydrocannabinol on murine lymphoid cells.Derivation of adult canine intestinal organoids for translational research in gastroenterologyInhibition of macrophage nitric oxide production by tetrahydrocannabinol in vivo and in vitroAccelerated clinical disease and pathology in mucopolysaccharidosis type IIIB and GalNAc transferase double knockout mice
P50
Q27312146-48089C43-6C74-4DB1-BA17-A7296ADCD18EQ30499512-08FEDEEC-71E1-4CAC-B09F-5D229BBAB0C1Q34153746-27EE173A-216A-4D81-A44A-B247B6DCAD49Q34176627-9DAD67C3-CB46-4C1B-A52B-C741766D47EFQ34446285-53F5AA2B-B812-4467-90F5-C489AAD19BCAQ35032587-274C082A-82E0-4A40-8136-D42109666711Q35069844-82810AE8-3BBF-4982-86F3-D31CF74A341FQ36278875-011A3889-9CCA-4322-96FE-490371384C21Q40986565-D98925BD-61B5-4B3B-9278-4920B2435665Q42346703-4D1F7E81-06C5-44FE-9221-F806BFD1727FQ45080100-C93A2ACA-4582-4048-B669-8E4888F28D52Q54155321-D3B3D38C-AE65-4286-9190-6649AA4FEB4CQ64053248-7E001C34-2B4A-4BD0-9767-B05D27BD3885Q73388582-8A32E6CA-BD9C-4D4B-AE74-9AD8D222D8ABQ84739890-7DEC833C-0B98-42B7-904F-828BDA27868E
P50
description
researcher
@en
name
E Snella
@en
E Snella
@nl
type
label
E Snella
@en
E Snella
@nl
prefLabel
E Snella
@en
E Snella
@nl
P106
P31
P496
0000-0003-1482-2876